Results 191 to 200 of about 358,537 (259)

Editorial: Pharmacogenomics of drug hypersensitivity reactions. [PDF]

Front Pharmacol
Kassogue Y, Fricke-Galindo I.
europepmc   +1 more source

Europium Doped Atomically Precise Bismuth Oxido Nanoclusters as Molecular Building Blocks for Photoluminescent Hybrid Materials

Chemistry – A European Journal, EarlyView.
Europium doping of bismuth oxido nanoclusters (BiO‐NCs) provides stable hosts for Eu3+ in an asymmetric coordination environment, which in turn results in an intense 5D0→7F0 transition and long luminescence lifetimes. Transparent hybrid materials showing characteristic red photoluminescence are accessible via radical copolymerisation of these soluble ...
Rico Thomas, Senthil Kumar Kuppusamy, Tobias Rüffer, Marcus Weber, Mario Ruben, Michael Mehring   +5 more
wiley   +1 more source

Reinterpreting Amitriptyline in Extra-esophageal Gastroesophageal Reflux Disease Through the GABAergic Inhibitory Axis. [PDF]

J Neurogastroenterol Motil
Xiao Q, Li Z, Yuan A, Xiao J.
europepmc   +1 more source

Formation of Lanthanide Luminescent Aggregates With RNA Using Tripodal Europium [Eu(III)] BTA Self‐Assembled Complexes

Chemistry – A European Journal, EarlyView.
The two Eu(III) complexes of 1.Eu and 2.Eu, that were formed in situ, were used to bind to yeast RNA and A10 (RNA) in a buffered pH 7 solution. The interaction gave rise to changes in the lanthanide‐centered emission because of direct binding of these complexes, which resulted in aggregation of the RNA, as demonstrated using phase‐contrast and atomic ...
Tómas A. Gudmundsson, Changzhuang Bai, Grace E. Maynard, Pall Thordarson, Thorfinnur Gunnlaugsson   +4 more
wiley   +1 more source

Suspected remimazolam formulation-associated peri-induction anaphylaxis: two cases highlighting diagnostic complexity - Two case reports. [PDF]

Anesth Pain Med (Seoul)
Lee HS, Lee MW, Oh D.
europepmc   +1 more source

Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?

Clinical Pharmacology &Therapeutics, EarlyView.
Pediatric drug development has achieved remarkable success in the last 20 years with over 1,000 products studied in pediatric patients. This success has been driven in part by an increased understanding of pediatric disease processes. The aspect that has been largely overlooked is the potential adverse effect of new drugs on pediatric developmental ...
Gilbert J. Burckart, Susan M. Abdel‐Rahman, Gelareh Abulwerdi, Sherbet Samuels, Rebecca Racz, Mohamed A. Mohamoud, Nicholas P. Tatonetti   +6 more
wiley   +1 more source

Emerging Clinical Complications of Alpha-Gal Syndrome: A Scoping Review. [PDF]

Cureus
Vundamati VS, Patel SR, Patel R, Eriskin N, Tila-Cohen B, Friedrich CJ, Gupta A, Neupane R, Arango S, Kesselman MM.   +9 more
europepmc   +1 more source

Adverse Reactions Identified after Approval of Novel Medicines: Analysis of 339 New Molecular Entities and Therapeutic Biologics

Clinical Pharmacology &Therapeutics, EarlyView.
Postmarketing safety surveillance data identify safety issues not identified in preapproval clinical trials. We describe the frequency of new safety issues overall and by labeling section and the relationship of the most commonly added safety issues with the cumulative number of prescriptions dispensed via retail pharmacies.
Ellen Pinnow, Brendan Day, Esther H. Zhou, Corinne Woods, Nana Dwumfour, Jenni Y. Lee, Ilynn Bulatao, Sanae Cherkaoui, Manish Kalaria, Sonja Brajovic, Nabila Sadiq, Farideh Sistani, Maggie Lee, Grace Chai, Gerald Dal Pan   +14 more
wiley   +1 more source

38% silver diamine fluoride for dentine hypersensitivity treatment: an <i>in situ</i> study. [PDF]

Front Oral Health
Chawhuaveang D, Chan AKY, Chu CH, Yu OY.
europepmc   +1 more source